CORCEPT THERAPEUTICS
CORT Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
Director
10% Owner
Mcap/AUM
2025-06-03
2025-06-04
MOKARI ATABAK
Chief Financial Officer
F - Tax
Common Stock
-519
$72.00
-37,368
1
$7.55B
2025-06-03
2025-06-04
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
F - Tax
Common Stock
-441
$72.00
-31,752
1
$7.55B
2025-06-03
2025-06-04
ROBB GARY CHARLES
Chief Business Officer
F - Tax
Common Stock
-651
$72.00
-46,872
1
$7.55B
2025-06-02
2025-06-04
MOKARI ATABAK
Chief Financial Officer
A - Grant
Common Stock
1,550
$36.00
55,800
2
$7.55B
2025-06-02
2025-06-04
ROBB GARY CHARLES
Chief Business Officer
A - Grant
Common Stock
1,994
$36.00
71,784
2
$7.55B
2025-06-02
2025-06-04
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Stock option (right to buy)
-5,000
$0.00
1
$7.55B
2025-06-02
2025-06-04
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Common Stock
5,000
$14.00
70,000
1
$7.55B
2025-06-02
2025-06-04
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Stock option (right to buy)
-20,000
$0.00
1
$7.55B
2025-06-02
2025-06-04
BELANOFF JOSEPH
Chief Executive Officer
S - Sale
Common Stock
-40,000
$83.00
-3.32M
8
$7.55B
2025-06-02
2025-06-04
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
S - Sale
Common Stock
-5,000
$78.00
-390K
2
$7.55B
2025-06-02
2025-06-04
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
Common Stock
-20,000
$79.00
-1.58M
4
$7.55B
2025-06-02
2025-06-04
MOKARI ATABAK
Chief Financial Officer
A - Grant
Common Stock
1,550
$36.00
55,800
2
$7.55B
2025-06-02
2025-06-04
ROBB GARY CHARLES
Chief Business Officer
A - Grant
Common Stock
1,994
$36.00
71,784
2
$7.55B
2025-06-02
2025-06-04
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Stock option (right to buy)
-5,000
$0.00
1
$7.55B
2025-06-02
2025-06-04
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Common Stock
5,000
$14.00
70,000
1
$7.55B
2025-06-02
2025-06-04
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Stock option (right to buy)
-20,000
$0.00
1
$7.55B
2025-06-02
2025-06-04
BELANOFF JOSEPH
Chief Executive Officer
S - Sale
Common Stock
-40,000
$83.00
-3.32M
8
$7.55B
2025-06-02
2025-06-04
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
S - Sale
Common Stock
-5,000
$78.00
-390K
2
$7.55B
2025-06-02
2025-06-04
MADUCK SEAN
President, Corcept Endocrinolo...
A - Grant
Common Stock
21,776
$8.00
174K
3
$7.55B
2025-06-02
2025-06-04
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
Common Stock
-20,000
$79.00
-1.58M
4
$7.55B
2025-06-02
2025-06-04
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
A - Grant
Common Stock
1,498
$36.00
53,928
2
$7.55B
2025-06-02
2025-06-04
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
A - Grant
Common Stock
1,498
$36.00
53,928
2
$7.55B
2025-06-02
2025-06-04
MADUCK SEAN
President, Corcept Endocrinolo...
A - Grant
Common Stock
21,776
$8.00
174K
3
$7.55B
2025-05-29
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Common Stock
10,000
$4.00
40,000
1
$7.55B
2025-05-29
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Stock option (right to buy)
-10,000
$0.00
1
$7.55B
2025-05-29
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
J - Other
Common Stock
10,000
$0.00
1
$7.55B
2025-05-29
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
G - Gift
Common Stock
-10,000
$0.00
1
$7.55B
2024-03-19
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
J - Other
Common Stock
10,000
$0.00
1
$7.55B
2024-03-19
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
G - Gift
Common Stock
-10,000
$0.00
1
$7.55B
2023-09-01
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
J - Other
Common Stock
1,059
$0.00
1
$7.55B
2023-09-01
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
G - Gift
Common Stock
-1,059
$0.00
1
$7.55B
2023-07-17
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
G - Gift
Common Stock
-10,000
$0.00
1
$7.55B
2023-07-17
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
J - Other
Common Stock
10,000
$0.00
1
$7.55B
2023-07-17
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
G - Gift
Common Stock
-10,000
$0.00
1
$7.55B
2023-07-17
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
J - Other
Common Stock
10,000
$0.00
1
$7.55B
2023-06-01
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
J - Other
Common Stock
1,658
$0.00
1
$7.55B
2023-06-01
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
G - Gift
Common Stock
-1,658
$0.00
1
$7.55B
2023-03-01
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
G - Gift
Common Stock
-1,460
$0.00
1
$7.55B
2023-03-01
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
J - Other
Common Stock
1,460
$0.00
1
$7.55B
2022-09-01
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
J - Other
Common Stock
922
$0.00
1
$7.55B
2022-09-01
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
G - Gift
Common Stock
-922
$0.00
1
$7.55B
2022-08-19
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
G - Gift
Common Stock
-14,594
$0.00
1
$7.55B
2022-08-19
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
J - Other
Common Stock
14,594
$0.00
1
$7.55B
2021-07-13
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
G - Gift
Common Stock
-10,000
$0.00
1
$7.55B
2021-07-13
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
J - Other
Common Stock
10,000
$0.00
1
$7.55B
2018-12-13
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
G - Gift
Common Stock
-10,000
$0.00
1
$7.55B
2018-12-13
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
J - Other
Common Stock
10,000
$0.00
1
$7.55B
2018-05-15
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
G - Gift
Common Stock
-10,000
$0.00
1
$7.55B
2018-05-15
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
J - Other
Common Stock
10,000
$0.00
1
$7.55B
2018-05-15
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
G - Gift
Common Stock
-10,000
$0.00
1
$7.55B
2018-05-15
2025-06-02
MADUCK SEAN
President, Corcept Endocrinolo...
J - Other
Common Stock
10,000
$0.00
1
$7.55B
2025-05-20
2025-05-22
ROBB GARY CHARLES
Chief Business Officer
G - Gift
Common Stock
-1,380
$0.00
1
$7.55B
2025-05-20
2025-05-22
ROBB GARY CHARLES
Chief Business Officer
S - Sale
Common Stock
-2,279
$76.00
-173K
1
$7.55B
2025-05-16
2025-05-20
GUYER WILLIAM
Chief Development Officer
M - Exercise
Stock option (right to buy)
-32,262
$0.00
1
$7.55B
2025-05-16
2025-05-20
GUYER WILLIAM
Chief Development Officer
M - Exercise
Common Stock
32,262
$22.00
710K
1
$7.55B
2025-05-16
2025-05-20
GUYER WILLIAM
Chief Development Officer
S - Sale
Common Stock
-32,262
$74.00
-2.39M
1
$7.55B
2025-05-06
2025-05-08
GUYER WILLIAM
Chief Development Officer
M - Exercise
Stock option (right to buy)
-7,060
$0.00
1
$7.55B
2025-05-06
2025-05-08
GUYER WILLIAM
Chief Development Officer
M - Exercise
Common Stock
7,060
$22.00
155K
1
$7.55B
2025-05-06
2025-05-08
GUYER WILLIAM
Chief Development Officer
S - Sale
Common Stock
-7,060
$74.00
-522K
1
$7.55B
2025-05-02
2025-05-05
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Stock option (right to buy)
-26,554
$0.00
1
$7.55B
2025-05-02
2025-05-05
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Common Stock
26,554
$5.00
133K
1
$7.55B
2025-05-02
2025-05-05
BELANOFF JOSEPH
Chief Executive Officer
S - Sale
Common Stock
-40,000
$73.00
-2.92M
2
$7.55B
2025-05-02
2025-05-05
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
Common Stock
-26,554
$72.00
-1.91M
2
$7.55B
2025-05-01
2025-05-05
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Common Stock
9,350
$14.00
131K
1
$7.55B
2025-05-01
2025-05-05
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Stock option (right to buy)
-12,856
$0.00
1
$7.55B
2025-05-01
2025-05-05
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Common Stock
12,856
$5.00
64,280
1
$7.55B
2025-05-01
2025-05-05
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
S - Sale
Common Stock
-9,350
$72.00
-673K
1
$7.55B
2025-05-01
2025-05-05
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
Common Stock
-12,856
$72.00
-926K
1
$7.55B
2025-05-01
2025-05-05
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Stock option (right to buy)
-9,350
$0.00
1
$7.55B
2025-05-02
2025-05-02
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
-20,000
$71.00
-1.42M
1
$7.55B
2025-05-01
2025-05-01
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
S - Sale
-5,000
$72.00
-360K
1
$7.55B
2025-04-01
2025-04-02
GUYER WILLIAM
Chief Development Officer
M - Exercise
Stock option (right to buy)
-678
$0.00
1
$7.55B
2025-04-01
2025-04-02
GUYER WILLIAM
Chief Development Officer
M - Exercise
Common Stock
678
$22.00
14,916
1
$7.55B
2025-04-01
2025-04-02
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Stock option (right to buy)
-650
$0.00
1
$7.55B
2025-04-01
2025-04-02
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Common Stock
650
$14.00
9,100
1
$7.55B
2025-04-01
2025-04-02
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Stock option (right to buy)
-590
$0.00
1
$7.55B
2025-04-01
2025-04-02
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Common Stock
590
$5.00
2,950
1
$7.55B
2025-04-01
2025-04-02
BELANOFF JOSEPH
Chief Executive Officer
S - Sale
Common Stock
-350
$115.00
-40,250
1
$7.55B
2025-04-01
2025-04-02
GUYER WILLIAM
Chief Development Officer
S - Sale
Common Stock
-678
$115.00
-77,970
1
$7.55B
2025-04-01
2025-04-02
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
S - Sale
Common Stock
-650
$115.00
-74,750
1
$7.55B
2025-04-01
2025-04-02
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
Common Stock
-590
$115.00
-67,850
1
$7.55B
2025-03-31
2025-04-02
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Stock option (right to buy)
-200K
$0.00
4
$7.55B
2025-03-31
2025-04-02
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
Common Stock
-100K
$101.00
-10M
3
$7.55B
2025-03-31
2025-04-02
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
S - Sale
Common Stock
-200K
$100.00
-20M
3
$7.55B
2025-03-31
2025-04-02
BELANOFF JOSEPH
Chief Executive Officer
S - Sale
Common Stock
-35,102
$95.00
-3.33M
1
$7.55B
2025-03-31
2025-04-02
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Common Stock
200K
$17.00
3.40M
4
$7.55B
2025-03-31
2025-04-02
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Common Stock
100K
$8.00
800K
1
$7.55B
2025-03-31
2025-04-02
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Stock option (right to buy)
-100K
$0.00
1
$7.55B
2025-04-01
2025-04-01
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
S - Sale
-5,000
$114.00
-570K
1
$7.55B
2025-04-01
2025-04-01
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
-20,000
$114.00
-2.28M
1
$7.55B
2025-03-24
2025-03-26
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Stock option (right to buy)
-421
$0.00
1
$7.55B
2025-03-24
2025-03-26
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Common Stock
421
$14.00
5,894
1
$7.55B
2025-03-24
2025-03-26
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Stock option (right to buy)
-1,697
$0.00
1
$7.55B
2025-03-24
2025-03-26
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Common Stock
1,697
$5.00
8,485
1
$7.55B
2025-03-24
2025-03-26
BELANOFF JOSEPH
Chief Executive Officer
S - Sale
Common Stock
-1,974
$61.00
-120K
1
$7.55B
2025-03-24
2025-03-26
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
S - Sale
Common Stock
-421
$61.00
-25,681
1
$7.55B
2025-03-24
2025-03-26
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
Common Stock
-1,697
$61.00
-104K
1
$7.55B
2025-03-12
2025-03-14
ROBB GARY CHARLES
Chief Business Officer
G - Gift
Common Stock
2,000
$0.00
2
$7.55B
2025-03-12
2025-03-14
ROBB GARY CHARLES
Chief Business Officer
G - Gift
Common Stock
-4,625
$0.00
1
$7.55B
2025-03-04
2025-03-04
GUYER WILLIAM
Chief Development Officer
M - Exercise
Stock option (right to buy)
-20,000
$0.00
1
$7.55B
2025-03-04
2025-03-04
GUYER WILLIAM
Chief Development Officer
M - Exercise
Common Stock
20,000
$19.00
380K
1
$7.55B
2025-03-04
2025-03-04
GUYER WILLIAM
Chief Development Officer
S - Sale
Common Stock
-20,000
$59.00
-1.18M
1
$7.55B
2025-03-03
2025-03-04
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
A - Grant
Common Stock
432
$30.00
12,960
2
$7.55B
2025-03-03
2025-03-04
MADUCK SEAN
President, Corcept Endocrinolo...
A - Grant
Common Stock
532
$30.00
15,960
2
$7.55B
2025-03-03
2025-03-04
MOKARI ATABAK
Chief Financial Officer
A - Grant
Common Stock
464
$30.00
13,920
2
$7.55B
2025-03-03
2025-03-04
ROBB GARY CHARLES
Chief Business Officer
A - Grant
Common Stock
584
$30.00
17,520
2
$7.55B
2025-03-03
2025-03-04
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
F - Tax
Common Stock
-182
$61.00
-11,102
1
$7.55B
2025-03-03
2025-03-04
MADUCK SEAN
President, Corcept Endocrinolo...
F - Tax
Common Stock
-228
$61.00
-13,908
1
$7.55B
2025-03-03
2025-03-04
MOKARI ATABAK
Chief Financial Officer
F - Tax
Common Stock
-228
$61.00
-13,908
1
$7.55B
2025-03-03
2025-03-04
ROBB GARY CHARLES
Chief Business Officer
F - Tax
Common Stock
-250
$61.00
-15,250
1
$7.55B
2025-03-03
2025-03-04
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Stock option (right to buy)
-4,579
$0.00
1
$7.55B
2025-03-03
2025-03-04
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Common Stock
4,579
$14.00
64,106
1
$7.55B
2025-03-03
2025-03-04
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Stock option (right to buy)
-18,303
$0.00
1
$7.55B
2025-03-03
2025-03-04
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Common Stock
18,303
$5.00
91,515
1
$7.55B
2025-03-03
2025-03-04
BELANOFF JOSEPH
Chief Executive Officer
S - Sale
Common Stock
-2,924
$61.00
-178K
1
$7.55B
2025-03-03
2025-03-04
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
S - Sale
Common Stock
-4,579
$61.00
-279K
1
$7.55B
2025-03-03
2025-03-04
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
Common Stock
-18,303
$61.00
-1.12M
1
$7.55B
2025-02-28
2025-03-04
MADUCK SEAN
President, Corcept Endocrinolo...
A - Grant
Stock option (right to buy)
140K
$0.00
1
$7.55B
2025-02-28
2025-03-04
BELANOFF JOSEPH
Chief Executive Officer
A - Grant
Stock option (right to buy)
350K
$0.00
1
$7.55B
2025-02-28
2025-03-04
GUYER WILLIAM
Chief Development Officer
A - Grant
Stock option (right to buy)
140K
$0.00
1
$7.55B
2025-02-28
2025-03-04
HUNT HAZEL
Chief Scientific Officer
A - Grant
Stock Option (right to buy)
140K
$0.00
1
$7.55B
2025-02-28
2025-03-04
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
A - Grant
Stock option (right to buy)
140K
$0.00
1
$7.55B
2025-02-28
2025-03-04
MOKARI ATABAK
Chief Financial Officer
A - Grant
Stock option (right to buy)
140K
$0.00
1
$7.55B
2025-02-28
2025-03-04
ROBB GARY CHARLES
Chief Business Officer
A - Grant
Stock option (right to buy)
140K
$0.00
1
$7.55B
2025-03-03
2025-03-03
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
S - Sale
-5,000
$61.00
-305K
1
$7.55B
2025-03-03
2025-03-03
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
-20,000
$61.00
-1.22M
1
$7.55B
2025-02-11
2025-02-13
HUNT HAZEL
Chief Scientific Officer
F - Tax
Common Stock
-85,176
$68.00
-5.79M
1
$7.55B
2025-02-11
2025-02-13
HUNT HAZEL
Chief Scientific Officer
M - Exercise
Stock Option (right to buy)
-150K
$0.00
1
$7.55B
2025-02-11
2025-02-13
HUNT HAZEL
Chief Scientific Officer
M - Exercise
Common Stock
150K
$3.00
450K
1
$7.55B
2025-02-03
2025-02-05
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Stock option (right to buy)
-5,000
$0.00
2
$7.55B
2025-02-03
2025-02-05
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Common Stock
5,000
$13.00
65,000
2
$7.55B
2025-02-03
2025-02-05
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Stock option (right to buy)
-20,000
$0.00
2
$7.55B
2025-02-03
2025-02-05
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Common Stock
20,000
$4.00
80,000
2
$7.55B
2025-02-03
2025-02-05
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
S - Sale
Common Stock
-5,000
$67.00
-335K
1
$7.55B
2025-02-03
2025-02-05
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
Common Stock
-20,000
$67.00
-1.34M
1
$7.55B
2025-01-03
2025-01-06
ROBB GARY CHARLES
Chief Business Officer
M - Exercise
Stock option (right to buy)
-3,037
$0.00
1
$7.55B
2025-01-03
2025-01-06
ROBB GARY CHARLES
Chief Business Officer
M - Exercise
Common Stock
3,037
$3.00
9,111
1
$7.55B
2025-01-02
2025-01-06
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
S - Sale
Common Stock
-5,000
$50.00
-250K
1
$7.55B
2025-01-02
2025-01-06
ROBB GARY CHARLES
Chief Business Officer
M - Exercise
Common Stock
11,000
$3.00
33,000
1
$7.55B
2025-01-02
2025-01-06
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Stock option (right to buy)
-5,000
$0.00
1
$7.55B
2025-01-02
2025-01-06
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Common Stock
5,000
$11.00
55,000
1
$7.55B
2025-01-02
2025-01-06
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Stock option (right to buy)
-20,000
$0.00
1
$7.55B
2025-01-02
2025-01-06
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Common Stock
20,000
$4.00
80,000
1
$7.55B
2025-01-02
2025-01-06
ROBB GARY CHARLES
Chief Business Officer
S - Sale
Common Stock
-11,000
$51.00
-561K
1
$7.55B
2025-01-02
2025-01-06
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
Common Stock
-20,000
$50.00
-1.00M
1
$7.55B
2025-01-02
2025-01-06
ROBB GARY CHARLES
Chief Business Officer
M - Exercise
Stock option (right to buy)
-11,000
$0.00
1
$7.55B
2024-12-02
2024-12-04
ROBB GARY CHARLES
Chief Business Officer
A - Grant
Common Stock
580
$30.00
17,400
2
$7.55B
2024-12-02
2024-12-04
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
A - Grant
Common Stock
430
$30.00
12,900
2
$7.55B
2024-12-02
2024-12-04
MADUCK SEAN
President, Corcept Endocrinolo...
A - Grant
Common Stock
530
$30.00
15,900
2
$7.55B
2024-12-02
2024-12-04
MOKARI ATABAK
Chief Financial Officer
A - Grant
Common Stock
462
$30.00
13,860
2
$7.55B
2024-12-02
2024-12-04
GUYER WILLIAM
Chief Development Officer
F - Tax
Common Stock
-309
$58.00
-17,922
1
$7.55B
2024-12-02
2024-12-04
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
F - Tax
Common Stock
-165
$58.00
-9,570
1
$7.55B
2024-12-02
2024-12-04
MADUCK SEAN
President, Corcept Endocrinolo...
F - Tax
Common Stock
-295
$58.00
-17,110
1
$7.55B
2024-12-02
2024-12-04
MOKARI ATABAK
Chief Financial Officer
F - Tax
Common Stock
-182
$58.00
-10,556
1
$7.55B
2024-12-02
2024-12-04
ROBB GARY CHARLES
Chief Business Officer
F - Tax
Common Stock
-324
$58.00
-18,792
1
$7.55B
2024-11-22
2024-11-26
ROBB GARY CHARLES
Chief Business Officer
S - Sale
Common Stock
-2,609
$56.00
-146K
1
$7.55B
2024-11-22
2024-11-26
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
S - Sale
Common Stock
-1,411
$57.00
-80,427
1
$7.55B
2024-11-04
2024-11-05
GUYER WILLIAM
Chief Development Officer
M - Exercise
Stock option (right to buy)
-3,394
$0.00
1
$7.55B
2024-11-04
2024-11-05
GUYER WILLIAM
Chief Development Officer
M - Exercise
Common Stock
3,394
$22.00
74,668
1
$7.55B
2024-11-04
2024-11-05
GUYER WILLIAM
Chief Development Officer
S - Sale
Common Stock
-3,394
$49.00
-166K
1
$7.55B
2024-11-01
2024-11-05
GUYER WILLIAM
Chief Development Officer
S - Sale
Common Stock
-6,606
$49.00
-324K
1
$7.55B
2024-11-01
2024-11-05
GUYER WILLIAM
Chief Development Officer
M - Exercise
Common Stock
6,606
$22.00
145K
1
$7.55B
2024-11-01
2024-11-05
GUYER WILLIAM
Chief Development Officer
M - Exercise
Stock option (right to buy)
-6,606
$0.00
1
$7.55B
2024-10-01
2024-10-03
GUYER WILLIAM
Chief Development Officer
M - Exercise
Stock option (right to buy)
-10,000
$0.00
1
$7.55B
2024-10-01
2024-10-03
GUYER WILLIAM
Chief Development Officer
M - Exercise
Common Stock
10,000
$22.00
220K
1
$7.55B
2024-10-01
2024-10-03
GUYER WILLIAM
Chief Development Officer
S - Sale
Common Stock
-10,000
$46.00
-460K
1
$7.55B
2024-10-01
2024-10-01
ROBB GARY CHARLES
Chief Business Officer
M - Exercise
Common Stock
11,000
$3.00
33,000
1
$7.55B
2024-10-01
2024-10-01
ROBB GARY CHARLES
Chief Business Officer
M - Exercise
Stock option (right to buy)
-11,000
$0.00
1
$7.55B
2024-10-01
2024-10-01
ROBB GARY CHARLES
Chief Business Officer
S - Sale
Common Stock
-11,000
$46.00
-506K
1
$7.55B
2024-09-18
2024-09-19
ROBB GARY CHARLES
Chief Business Officer
J - Other
Common Stock
-7,250
$0.00
1
$7.55B
2024-09-03
2024-09-05
ROBB GARY CHARLES
Chief Business Officer
A - Grant
Common Stock
1,006
$17.00
17,102
2
$7.55B
2024-09-03
2024-09-05
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
F - Tax
Common Stock
-129
$35.00
-4,515
1
$7.55B
2024-09-03
2024-09-05
MADUCK SEAN
President, Corcept Endocrinolo...
F - Tax
Common Stock
-232
$35.00
-8,120
1
$7.55B
2024-09-03
2024-09-05
MOKARI ATABAK
Chief Financial Officer
F - Tax
Common Stock
-143
$35.00
-5,005
1
$7.55B
2024-09-03
2024-09-05
ROBB GARY CHARLES
Chief Business Officer
F - Tax
Common Stock
-254
$35.00
-8,890
1
$7.55B
2024-09-03
2024-09-05
GUYER WILLIAM
Chief Development Officer
M - Exercise
Stock option (right to buy)
-10,000
$0.00
1
$7.55B
2024-09-03
2024-09-05
GUYER WILLIAM
Chief Development Officer
M - Exercise
Common Stock
10,000
$22.00
220K
1
$7.55B
2024-09-03
2024-09-05
GUYER WILLIAM
Chief Development Officer
S - Sale
Common Stock
-10,000
$35.00
-350K
1
$7.55B
2024-09-03
2024-09-05
GUYER WILLIAM
Chief Development Officer
F - Tax
Common Stock
-243
$35.00
-8,505
1
$7.55B
2024-09-03
2024-09-05
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
A - Grant
Common Stock
744
$17.00
12,648
2
$7.55B
2024-09-03
2024-09-05
MADUCK SEAN
President, Corcept Endocrinolo...
A - Grant
Common Stock
916
$17.00
15,572
2
$7.55B
2024-09-03
2024-09-05
MOKARI ATABAK
Chief Financial Officer
A - Grant
Common Stock
800
$17.00
13,600
2
$7.55B
2024-08-26
2024-08-28
ROBB GARY CHARLES
Chief Business Officer
S - Sale
Common Stock
-3,101
$36.00
-112K
1
$7.55B
2024-08-01
2024-08-05
HUNT HAZEL
Chief Scientific Officer
F - Tax
Common Stock
-34,773
$38.00
-1.32M
1
$7.55B
2024-08-01
2024-08-05
GUYER WILLIAM
Chief Development Officer
M - Exercise
Stock option (right to buy)
-10,000
$0.00
1
$7.55B
2024-08-01
2024-08-05
GUYER WILLIAM
Chief Development Officer
M - Exercise
Common Stock
10,000
$22.00
220K
1
$7.55B
2024-08-01
2024-08-05
HUNT HAZEL
Chief Scientific Officer
M - Exercise
Stock Option (right to buy)
-60,000
$0.00
1
$7.55B
2024-08-01
2024-08-05
HUNT HAZEL
Chief Scientific Officer
M - Exercise
Common Stock
60,000
$3.00
180K
1
$7.55B
2024-08-01
2024-08-05
GUYER WILLIAM
Chief Development Officer
S - Sale
Common Stock
-10,000
$39.00
-390K
1
$7.55B
2024-07-31
2024-08-02
BELANOFF JOSEPH
Chief Executive Officer
F - Tax
Common Stock
-260K
$39.00
-10M
1
$7.55B
2024-07-31
2024-08-02
BELANOFF JOSEPH
Chief Executive Officer
M - Exercise
Stock option (right to buy)
-450K
$0.00
1
$7.55B
2024-07-31
2024-08-02
BELANOFF JOSEPH
Chief Executive Officer
M - Exercise
Common Stock
450K
$3.00
1.35M
1
$7.55B
2024-07-01
2024-07-03
GUYER WILLIAM
Chief Development Officer
M - Exercise
Stock option (right to buy)
-10,000
$0.00
1
$7.55B
2024-07-01
2024-07-03
GUYER WILLIAM
Chief Development Officer
M - Exercise
Common Stock
10,000
$22.00
220K
1
$7.55B
2024-07-01
2024-07-03
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Stock option (right to buy)
-5,000
$0.00
1
$7.55B
2024-07-01
2024-07-03
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Common Stock
5,000
$11.00
55,000
1
$7.55B
2024-07-01
2024-07-03
ROBB GARY CHARLES
Chief Business Officer
M - Exercise
Stock option (right to buy)
-11,000
$0.00
1
$7.55B
2024-07-01
2024-07-03
ROBB GARY CHARLES
Chief Business Officer
M - Exercise
Common Stock
11,000
$3.00
33,000
1
$7.55B
2024-07-01
2024-07-03
GUYER WILLIAM
Chief Development Officer
S - Sale
Common Stock
-10,000
$32.00
-320K
1
$7.55B
2024-07-01
2024-07-03
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
S - Sale
Common Stock
-5,000
$32.00
-160K
1
$7.55B
2024-07-01
2024-07-03
ROBB GARY CHARLES
Chief Business Officer
S - Sale
Common Stock
-11,000
$32.00
-352K
1
$7.55B
2024-06-24
2024-06-24
ROBB GARY CHARLES
Chief Business Officer
G - Gift
Common Stock
1,650
$0.00
3
$7.55B
2024-06-24
2024-06-24
ROBB GARY CHARLES
Chief Business Officer
G - Gift
Common Stock
-2,650
$0.00
1
$7.55B
2024-06-24
2024-06-24
ROBB GARY CHARLES
Chief Business Officer
J - Other
Common Stock
-1,000
$0.00
1
$7.55B
2024-06-04
2024-06-06
ROBB GARY CHARLES
Chief Business Officer
F - Tax
Common Stock
-8,174
$33.00
-270K
1
$7.55B
2024-06-04
2024-06-06
ROBB GARY CHARLES
Chief Business Officer
M - Exercise
Stock option (right to buy)
-14,000
$0.00
1
$7.55B
2024-06-04
2024-06-06
ROBB GARY CHARLES
Chief Business Officer
M - Exercise
Common Stock
14,000
$3.00
42,000
1
$7.55B
2024-06-03
2024-06-05
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
A - Grant
Common Stock
2,464
$16.00
39,424
2
$7.55B
2024-06-03
2024-06-05
MOKARI ATABAK
Chief Financial Officer
A - Grant
Common Stock
2,896
$16.00
46,336
2
$7.55B
2024-06-03
2024-06-05
ROBB GARY CHARLES
Chief Business Officer
A - Grant
Common Stock
3,636
$16.00
58,176
2
$7.55B
2024-06-03
2024-06-05
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
F - Tax
Common Stock
-488
$30.00
-14,640
1
$7.55B
2024-06-03
2024-06-05
MADUCK SEAN
President, Corcept Endocrinolo...
F - Tax
Common Stock
-823
$30.00
-24,690
1
$7.55B
2024-06-03
2024-06-05
MOKARI ATABAK
Chief Financial Officer
F - Tax
Common Stock
-571
$30.00
-17,130
1
$7.55B
2024-06-03
2024-06-05
ROBB GARY CHARLES
Chief Business Officer
F - Tax
Common Stock
-724
$30.00
-21,720
1
$7.55B
2024-06-03
2024-06-05
GUYER WILLIAM
Chief Development Officer
M - Exercise
Stock option (right to buy)
-10,000
$0.00
1
$7.55B
2024-06-03
2024-06-05
GUYER WILLIAM
Chief Development Officer
M - Exercise
Common Stock
10,000
$19.00
190K
1
$7.55B
2024-06-03
2024-06-05
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Stock option (right to buy)
-5,000
$0.00
1
$7.55B
2024-06-03
2024-06-05
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Common Stock
5,000
$11.00
55,000
1
$7.55B
2024-06-03
2024-06-05
GUYER WILLIAM
Chief Development Officer
S - Sale
Common Stock
-10,000
$32.00
-320K
1
$7.55B
2024-06-03
2024-06-05
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
S - Sale
Common Stock
-5,000
$30.00
-150K
1
$7.55B
2024-05-28
2024-05-30
GUYER WILLIAM
Chief Development Officer
M - Exercise
Stock option (right to buy)
-30,000
$0.00
1
$7.55B
2024-05-28
2024-05-30
GUYER WILLIAM
Chief Development Officer
M - Exercise
Common Stock
30,000
$19.00
570K
1
$7.55B
2024-05-28
2024-05-30
ROBB GARY CHARLES
Chief Business Officer
M - Exercise
Stock option (right to buy)
-11,000
$0.00
1
$7.55B
2024-05-28
2024-05-30
ROBB GARY CHARLES
Chief Business Officer
M - Exercise
Common Stock
11,000
$3.00
33,000
1
$7.55B
2024-05-28
2024-05-30
GUYER WILLIAM
Chief Development Officer
S - Sale
Common Stock
-30,000
$32.00
-960K
1
$7.55B
2024-05-28
2024-05-30
ROBB GARY CHARLES
Chief Business Officer
S - Sale
Common Stock
-11,000
$30.00
-330K
1
$7.55B
2024-05-13
2024-05-15
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Stock option (right to buy)
-50,000
$0.00
1
$7.55B
2024-05-13
2024-05-15
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Common Stock
50,000
$4.00
200K
1
$7.55B
2024-05-13
2024-05-15
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
Common Stock
-50,000
$28.00
-1.40M
1
$7.55B
2024-05-09
2024-05-13
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Common Stock
7,227
$11.00
79,497
1
$7.55B
2024-05-09
2024-05-13
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Stock option (right to buy)
-7,227
$0.00
1
$7.55B
2024-05-09
2024-05-13
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
S - Sale
Common Stock
-7,227
$26.00
-188K
1
$7.55B
2024-05-09
2024-05-09
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
S - Sale
-5,000
$25.00
-125K
1
$7.55B
2024-05-02
2024-05-06
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
S - Sale
Common Stock
-10,830
$26.00
-282K
1
$7.55B
2024-05-02
2024-05-06
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Stock option (right to buy)
-10,830
$0.00
1
$7.55B
2024-05-02
2024-05-06
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Common Stock
10,830
$11.00
119K
1
$7.55B
2024-04-04
2024-04-08
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Stock option (right to buy)
-5,443
$0.00
1
$7.55B
2024-04-04
2024-04-08
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Common Stock
5,443
$11.00
59,873
1
$7.55B
2024-04-04
2024-04-08
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
S - Sale
Common Stock
-5,443
$26.00
-142K
1
$7.55B
2024-04-04
2024-04-04
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
S - Sale
-10,000
$26.00
-260K
1
$7.55B
2024-04-01
2024-04-03
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Common Stock
500
$11.00
5,500
1
$7.55B
2024-04-01
2024-04-03
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
M - Exercise
Stock option (right to buy)
-500
$0.00
1
$7.55B
2024-04-01
2024-04-03
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
S - Sale
Common Stock
-500
$26.00
-13,000
1
$7.55B
2024-03-27
2024-03-29
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Common Stock
25,953
$4.00
104K
1
$7.55B
2024-03-27
2024-03-29
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Stock option (right to buy)
-25,953
$0.00
1
$7.55B
2024-03-27
2024-03-29
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
Common Stock
-25,953
$25.00
-649K
1
$7.55B
2024-03-27
2024-03-27
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
-25,000
$25.00
-625K
1
$7.55B
2024-03-19
2024-03-20
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Stock option (right to buy)
-10,000
$0.00
1
$7.55B
2024-03-19
2024-03-20
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Common Stock
10,000
$3.00
30,000
1
$7.55B
2024-03-18
2024-03-20
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Stock option (right to buy)
-17,219
$0.00
1
$7.55B
2024-03-18
2024-03-20
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Common Stock
17,219
$4.00
68,876
1
$7.55B
2024-03-18
2024-03-20
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
Common Stock
-17,219
$25.00
-430K
1
$7.55B
2024-03-01
2024-03-05
ROBB GARY CHARLES
Chief Business Officer
F - Tax
Common Stock
-656
$24.00
-15,744
1
$7.55B
2024-03-01
2024-03-05
LYON JOSEPH DOUGLAS
Chief Accounting Officer
A - Grant
Common Stock
1,014
$12.00
12,168
2
$7.55B
2024-03-01
2024-03-05
MADUCK SEAN
President, Corcept Endocrinolo...
A - Grant
Common Stock
1,272
$12.00
15,264
2
$7.55B
2024-03-01
2024-03-05
MOKARI ATABAK
Chief Financial Officer
A - Grant
Common Stock
1,108
$12.00
13,296
2
$7.55B
2024-03-01
2024-03-05
ROBB GARY CHARLES
Chief Business Officer
A - Grant
Common Stock
1,394
$12.00
16,728
2
$7.55B
2024-03-01
2024-03-05
GUYER WILLIAM
Chief Development Officer
F - Tax
Common Stock
-604
$24.00
-14,496
1
$7.55B
2024-03-01
2024-03-05
LYON JOSEPH DOUGLAS
Chief Accounting Officer
F - Tax
Common Stock
-474
$24.00
-11,376
1
$7.55B
2024-03-01
2024-03-05
MADUCK SEAN
President, Corcept Endocrinolo...
F - Tax
Common Stock
-505
$24.00
-12,120
1
$7.55B
2024-03-01
2024-03-05
MOKARI ATABAK
Chief Financial Officer
F - Tax
Common Stock
-517
$24.00
-12,408
1
$7.55B
2024-02-16
2024-02-21
LYON JOSEPH DOUGLAS
Chief Accounting Officer
M - Exercise
Common Stock
1,000
$11.00
11,000
1
$7.55B
2024-02-16
2024-02-21
LYON JOSEPH DOUGLAS
Chief Accounting Officer
M - Exercise
Stock option (right to buy)
-1,000
$0.00
1
$7.55B
2024-02-16
2024-02-21
LYON JOSEPH DOUGLAS
Chief Accounting Officer
S - Sale
Common Stock
-1,000
$26.00
-26,000
1
$7.55B
2024-02-16
2024-02-20
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
Common Stock
-27,068
$26.00
-704K
1
$7.55B
2024-02-16
2024-02-20
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Stock Option (right to buy)
-27,068
$0.00
2
$7.55B
2024-02-16
2024-02-20
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Common Stock
27,068
$4.00
108K
2
$7.55B
2024-02-15
2024-02-20
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Stock option (right to buy)
-4,760
$0.00
1
$7.55B
2024-02-15
2024-02-20
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Common Stock
4,760
$3.00
14,280
1
$7.55B
2024-02-15
2024-02-20
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
Common Stock
-4,760
$25.00
-119K
1
$7.55B
2024-02-16
2024-02-16
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
S - Sale
-10,000
$24.00
-240K
1
$7.55B
2024-02-15
2024-02-15
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
-50,000
$24.00
-1.20M
1
$7.55B
2024-02-09
2024-02-13
BELANOFF JOSEPH
Chief Executive Officer
A - Grant
Stock option (right to buy)
500K
$0.00
1
$7.55B
2024-02-09
2024-02-13
GUYER WILLIAM
Chief Development Officer
A - Grant
Stock option (right to buy)
200K
$0.00
1
$7.55B
2024-02-09
2024-02-13
HUNT HAZEL
Chief Scientific Officer
A - Grant
Stock option (right to buy)
200K
$0.00
1
$7.55B
2024-02-09
2024-02-13
LYON JOSEPH DOUGLAS
Chief Accounting Officer
A - Grant
Stock option (right to buy)
150K
$0.00
1
$7.55B
2024-02-09
2024-02-13
MADUCK SEAN
President, Corcept Endocrinolo...
A - Grant
Stock option (right to buy)
200K
$0.00
1
$7.55B
2024-02-09
2024-02-13
MOKARI ATABAK
Chief Financial Officer
A - Grant
Stock option (right to buy)
200K
$0.00
1
$7.55B
2024-02-09
2024-02-13
ROBB GARY CHARLES
Chief Business Officer
A - Grant
Stock option (right to buy)
200K
$0.00
1
$7.55B
2023-02-22
2024-02-12
ROBB GARY CHARLES
Chief Business Officer
G - Gift
Common Stock
-1,175
$0.00
1
$7.55B
2024-01-08
2024-01-12
HUNT HAZEL
Chief Scientific Officer
F - Tax
Common Stock
-29,792
$27.00
-804K
1
$7.55B
2024-01-08
2024-01-12
HUNT HAZEL
Chief Scientific Officer
M - Exercise
Stock Option (right to buy)
-50,000
$0.00
1
$7.55B
2024-01-08
2024-01-12
HUNT HAZEL
Chief Scientific Officer
M - Exercise
Common Stock
50,000
$3.00
150K
1
$7.55B
2023-12-22
2023-12-22
GUYER WILLIAM
Chief Development Officer
M - Exercise
Stock Option (right to buy)
-10,000
$0.00
1
$7.55B
2023-12-22
2023-12-22
GUYER WILLIAM
Chief Development Officer
M - Exercise
Common Stock
10,000
$19.00
190K
1
$7.55B
2023-12-22
2023-12-22
GUYER WILLIAM
Chief Development Officer
S - Sale
Common Stock
-10,000
$32.00
-320K
1
$7.55B
2023-12-13
2023-12-15
ROBB GARY CHARLES
Chief Business Officer
J - Other
Common Stock
-1,000
$0.00
1
$7.55B
2023-12-08
2023-12-12
ROBB GARY CHARLES
Chief Business Officer
G - Gift
Common Stock
1,917
$0.00
3
$7.55B
2023-12-06
2023-12-06
ROBB GARY CHARLES
Chief Business Officer
S - Sale
Common Stock
-6,212
$27.00
-168K
1
$7.55B
2023-12-05
2023-12-06
ROBB GARY CHARLES
Chief Business Officer
S - Sale
Common Stock
-1,381
$26.00
-35,906
1
$7.55B
2023-12-04
2023-12-06
ROBB GARY CHARLES
Chief Business Officer
M - Exercise
Common Stock
15,000
$3.00
45,000
1
$7.55B
2023-12-04
2023-12-06
ROBB GARY CHARLES
Chief Business Officer
F - Tax
Common Stock
-8,788
$26.00
-228K
1
$7.55B
2023-12-04
2023-12-06
ROBB GARY CHARLES
Chief Business Officer
M - Exercise
Stock option (right to buy)
-15,000
$0.00
1
$7.55B
2023-12-04
2023-12-05
LYON JOSEPH DOUGLAS
Chief Accounting Officer
S - Sale
Common Stock
-2,432
$26.00
-63,232
1
$7.55B
2023-12-04
2023-12-05
LYON JOSEPH DOUGLAS
Chief Accounting Officer
M - Exercise
Common Stock
2,432
$11.00
26,752
1
$7.55B
2023-12-01
2023-12-05
MADUCK SEAN
President, Corcept Endocrinolo...
A - Grant
Common Stock
1,164
$13.00
15,132
2
$7.55B
2023-12-01
2023-12-05
GUYER WILLIAM
Chief Development Officer
A - Grant
Common Stock
1,218
$13.00
15,834
2
$7.55B
2023-12-01
2023-12-05
LYON JOSEPH DOUGLAS
Chief Accounting Officer
A - Grant
Common Stock
920
$13.00
11,960
2
$7.55B
2023-12-01
2023-12-05
MOKARI ATABAK
Chief Financial Officer
A - Grant
Common Stock
1,016
$13.00
13,208
2
$7.55B
2023-12-01
2023-12-05
ROBB GARY CHARLES
Chief Business Officer
A - Grant
Common Stock
1,276
$13.00
16,588
2
$7.55B
2023-12-01
2023-12-05
LYON JOSEPH DOUGLAS
Chief Accounting Officer
M - Exercise
Stock option (right to buy)
-5,000
$0.00
1
$7.55B
2023-12-01
2023-12-05
LYON JOSEPH DOUGLAS
Chief Accounting Officer
M - Exercise
Common Stock
2,568
$11.00
28,248
1
$7.55B
2023-12-01
2023-12-05
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Stock option (right to buy)
-25,000
$0.00
2
$7.55B
2023-12-01
2023-12-05
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Common Stock
25,000
$3.00
75,000
2
$7.55B
2023-12-01
2023-12-05
LYON JOSEPH DOUGLAS
Chief Accounting Officer
S - Sale
Common Stock
-2,568
$26.00
-66,768
1
$7.55B
2023-12-01
2023-12-05
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
Common Stock
-25,000
$26.00
-650K
1
$7.55B
2023-12-01
2023-12-01
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
S - Sale
-5,000
$25.00
-125K
1
$7.55B
2023-11-02
2023-11-03
LYON JOSEPH DOUGLAS
Chief Accounting Officer
M - Exercise
Common Stock
3,977
$11.00
43,747
1
$7.55B
2023-11-02
2023-11-03
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Stock option (right to buy)
-19,888
$0.00
1
$7.55B
2023-11-02
2023-11-03
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Common Stock
19,888
$3.00
59,664
1
$7.55B
2023-11-02
2023-11-03
LYON JOSEPH DOUGLAS
Chief Accounting Officer
S - Sale
Common Stock
-3,977
$28.00
-111K
1
$7.55B
2023-11-02
2023-11-03
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
Common Stock
-19,888
$28.00
-557K
1
$7.55B
2023-11-02
2023-11-03
LYON JOSEPH DOUGLAS
Chief Accounting Officer
M - Exercise
Stock option (right to buy)
-3,977
$0.00
1
$7.55B
2023-11-01
2023-11-03
LYON JOSEPH DOUGLAS
Chief Accounting Officer
M - Exercise
Common Stock
1,023
$11.00
11,253
1
$7.55B
2023-11-01
2023-11-03
LYON JOSEPH DOUGLAS
Chief Accounting Officer
M - Exercise
Stock option (right to buy)
-1,023
$0.00
1
$7.55B
2023-11-01
2023-11-03
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Stock option (right to buy)
-5,112
$0.00
1
$7.55B
2023-11-01
2023-11-03
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Common Stock
5,112
$3.00
15,336
1
$7.55B
2023-11-01
2023-11-03
LYON JOSEPH DOUGLAS
Chief Accounting Officer
S - Sale
Common Stock
-1,023
$28.00
-28,644
1
$7.55B
2023-11-01
2023-11-03
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
Common Stock
-5,112
$28.00
-143K
1
$7.55B
2023-11-01
2023-11-01
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
S - Sale
-5,000
$28.00
-140K
1
$7.55B
2023-11-01
2023-11-01
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
-25,000
$28.00
-700K
1
$7.55B
2023-10-10
2023-10-12
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
Common Stock
-18,471
$27.00
-499K
1
$7.55B
2023-10-10
2023-10-12
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Stock option (right to buy)
-18,471
$0.00
2
$7.55B
2023-10-10
2023-10-12
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Common Stock
18,471
$3.00
55,413
2
$7.55B
2023-10-06
2023-10-10
LYON JOSEPH DOUGLAS
Chief Accounting Officer
S - Sale
Common Stock
-2,582
$27.00
-69,714
1
$7.55B
2023-10-06
2023-10-10
LYON JOSEPH DOUGLAS
Chief Accounting Officer
M - Exercise
Stock option (right to buy)
-2,582
$0.00
1
$7.55B
2023-10-06
2023-10-10
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
Common Stock
-3,498
$27.00
-94,446
1
$7.55B
2023-10-06
2023-10-10
LYON JOSEPH DOUGLAS
Chief Accounting Officer
M - Exercise
Common Stock
2,582
$11.00
28,402
1
$7.55B
2023-10-06
2023-10-10
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Stock option (right to buy)
-3,498
$0.00
1
$7.55B
2023-10-06
2023-10-10
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Common Stock
3,498
$3.00
10,494
1
$7.55B
2023-10-02
2023-10-04
LYON JOSEPH DOUGLAS
Chief Accounting Officer
S - Sale
Common Stock
-2,418
$27.00
-65,286
1
$7.55B
2023-10-02
2023-10-04
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
Common Stock
-3,031
$27.00
-81,837
1
$7.55B
2023-10-02
2023-10-04
LYON JOSEPH DOUGLAS
Chief Accounting Officer
M - Exercise
Stock option (right to buy)
-2,418
$0.00
1
$7.55B
2023-10-02
2023-10-04
LYON JOSEPH DOUGLAS
Chief Accounting Officer
M - Exercise
Common Stock
2,418
$11.00
26,598
1
$7.55B
2023-10-02
2023-10-04
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Stock option (right to buy)
-3,031
$0.00
1
$7.55B
2023-10-02
2023-10-04
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Common Stock
3,031
$3.00
9,093
1
$7.55B
2023-10-02
2023-10-02
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
S - Sale
-5,000
$27.00
-135K
1
$7.55B
2023-10-02
2023-10-02
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
-25,000
$27.00
-675K
1
$7.55B
2023-09-19
2023-09-20
MADUCK SEAN
President, Corcept Endocrinolo...
S - Sale
Common Stock
-25,000
$32.00
-800K
1
$7.55B
2023-09-19
2023-09-20
ROBB GARY CHARLES
Chief Business Officer
S - Sale
Common Stock
-5,000
$33.00
-165K
1
$7.55B
2023-09-18
2023-09-20
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Stock option (right to buy)
-25,000
$0.00
1
$7.55B
2023-09-18
2023-09-20
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Common Stock
25,000
$3.00
75,000
1
$7.55B
2023-09-14
2023-09-18
ROBB GARY CHARLES
Chief Business Officer
M - Exercise
Common Stock
13,963
$3.00
41,889
1
$7.55B
2023-09-14
2023-09-18
ROBB GARY CHARLES
Chief Business Officer
F - Tax
Common Stock
-7,996
$34.00
-272K
1
$7.55B
2023-09-14
2023-09-18
ROBB GARY CHARLES
Chief Business Officer
M - Exercise
Stock option (right to buy)
13,963
$0.00
1
$7.55B
2023-09-01
2023-09-06
MOKARI ATABAK
Chief Financial Officer
A - Grant
Common Stock
796
$17.00
13,532
2
$7.55B
2023-09-01
2023-09-06
ROBB GARY CHARLES
Chief Business Officer
A - Grant
Common Stock
1,000
$17.00
17,000
2
$7.55B
2023-09-01
2023-09-06
LYON JOSEPH DOUGLAS
Chief Accounting Officer
M - Exercise
Stock Option (right to buy)
-5,000
$0.00
1
$7.55B
2023-09-01
2023-09-06
LYON JOSEPH DOUGLAS
Chief Accounting Officer
M - Exercise
Common Stock
5,000
$11.00
55,000
1
$7.55B
2023-09-01
2023-09-06
LYON JOSEPH DOUGLAS
Chief Accounting Officer
S - Sale
Common Stock
-5,000
$33.00
-165K
1
$7.55B
2023-09-01
2023-09-06
GUYER WILLIAM
Chief Development Officer
A - Grant
Common Stock
956
$17.00
16,252
2
$7.55B
2023-09-01
2023-09-06
LYON JOSEPH DOUGLAS
Chief Accounting Officer
A - Grant
Common Stock
722
$17.00
12,274
2
$7.55B
2023-09-01
2023-09-06
MADUCK SEAN
President, Corcept Endocrinolo...
A - Grant
Common Stock
912
$17.00
15,504
2
$7.55B
2023-08-21
2023-08-22
LYON JOSEPH DOUGLAS
Chief Accounting Officer
M - Exercise
Stock option (right to buy)
-4,588
$0.00
2
$7.55B
2023-08-21
2023-08-22
LYON JOSEPH DOUGLAS
Chief Accounting Officer
M - Exercise
Common Stock
4,588
$9.00
41,292
2
$7.55B
2023-08-21
2023-08-22
LYON JOSEPH DOUGLAS
Chief Accounting Officer
S - Sale
Common Stock
-4,588
$31.00
-142K
1
$7.55B
2023-08-14
2023-08-15
HUNT HAZEL
Chief Scientific Officer
S - Sale
Common Stock
-20,455
$31.00
-634K
1
$7.55B
2023-08-08
2023-08-09
HUNT HAZEL
Chief Scientific Officer
F - Tax
Common Stock
-29,545
$30.00
-886K
1
$7.55B
2023-08-08
2023-08-09
HUNT HAZEL
Chief Scientific Officer
M - Exercise
Stock option (right to buy)
-50,000
$0.00
1
$7.55B
2023-08-08
2023-08-09
HUNT HAZEL
Chief Scientific Officer
M - Exercise
Common Stock
50,000
$3.00
150K
1
$7.55B
2023-08-07
2023-08-09
LYON JOSEPH DOUGLAS
Chief Accounting Officer
S - Sale
Common Stock
-412
$31.00
-12,772
1
$7.55B
2023-08-07
2023-08-09
LYON JOSEPH DOUGLAS
Chief Accounting Officer
M - Exercise
Common Stock
412
$8.00
3,296
1
$7.55B
2023-08-07
2023-08-09
LYON JOSEPH DOUGLAS
Chief Accounting Officer
M - Exercise
Stock Option (Right to Buy)
-412
$0.00
1
$7.55B
2023-08-07
2023-08-07
LYON JOSEPH DOUGLAS
Chief Accounting & Technology ...
S - Sale
-5,000
$31.00
-155K
1
$7.55B
2023-07-17
2023-07-19
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Common Stock
10,000
$2.00
20,000
1
$7.55B
2023-07-17
2023-07-19
MADUCK SEAN
President, Corcept Endocrinolo...
M - Exercise
Stock option (right to buy)
-10,000
$0.00
1
$7.55B
2023-06-08
2023-06-12
ROBB GARY CHARLES
Chief Business Officer
G - Gift
Common Stock
2,175
$0.00
3
$7.55B
2023-06-08
2023-06-12
ROBB GARY CHARLES
Chief Business Officer
G - Gift
Common Stock
-3,550
$0.00
5
$7.55B
2023-06-06
2023-06-07
LYON JOSEPH DOUGLAS
Chief Accounting Officer
M - Exercise
Stock option (right to buy)
-10,000
$0.00
1
$7.55B
2023-06-06
2023-06-07
LYON JOSEPH DOUGLAS
Chief Accounting Officer
M - Exercise
Common Stock
10,000
$11.00
110K
1
$7.55B
2023-06-06
2023-06-07
LYON JOSEPH DOUGLAS
Chief Accounting Officer
S - Sale
Common Stock
-10,000
$24.00
-240K
1
$7.55B
2023-06-01
2023-06-05
LYON JOSEPH DOUGLAS
Chief Accounting Officer
A - Grant
Common Stock
2,822
$11.00
31,042
2
$7.55B
2023-06-01
2023-06-05
MADUCK SEAN
President, Corcept Endocrinolo...
A - Grant
Common Stock
3,316
$11.00
36,476
2
$7.55B
2023-06-01
2023-06-05
MOKARI ATABAK
Chief Financial Officer
A - Grant
Common Stock
3,302
$11.00
36,322
2
$7.55B
2023-06-01
2023-06-05
ROBB GARY CHARLES
Chief Business Officer
A - Grant
Common Stock
4,182
$11.00
46,002
2
$7.55B
2023-05-10
2023-05-11
ROBB GARY CHARLES
Chief Business Officer
S - Sale
Common Stock
-14,000
$24.00
-336K
1
$7.55B